Venn Life Sciences is a European CRO with over 24 years’ experience in the management & resourcing of clinical trials. We have worked acrosss all phases of clinical research, with extensive experience in multiple therapeutic and device areas.

We have worked with leading pharmaceutical, biotech and medical device companies seeking to navigate the often difficult European clinical trial landscape. We have senior management teams that have worked internationally on a range of different trial sizes, who are directly involved in the preparation, management and implemention of study activities.

Over the years our high rate of repeat business highlights our commitment to give our clients a service that is over and above what is expected of a CRO. We understand the importance of fair pricing, attention to detail and consistency in terms of project teams. These qualities are what make us a leading CRO in Europe and with just under 300 trials completed, we have the capabilities to place therapeutically aligned clinical staff on all our sponsor projects.



http://vennlifesciences.com/

10:25 02/11/2016
Director Deals - Venn Life Sciences Holdings PLC (VENN)
Allan Wood, Chairman, bought 230,000 shares in the company on the 31st October 2016 at a price of 21.67p. The Director now holds 230,000 shares. NOTE: Average price over 2 transactions. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com